Rodriguez, Paloma
San Martin, Vicente T.
Pantalone, Kevin M.
Article History
Received: 9 November 2023
Accepted: 5 January 2024
First Online: 25 January 2024
Declarations
:
: Dr. Kevin M. Pantalone reported receiving consulting honoraria from AstraZeneca, Bayer, Corcept Therapeutics, Diasome, Eli Lilly, Merck, Novo Nordisk, and Sanofi; speaker honoraria from AstraZeneca, Corcept Therapeutics, Merck and Novo Nordisk; and research support from Bayer, Merck, Novo Nordisk, and Twin Health. Dr. Paloma Rodriguez reports no conflicts of interest to disclose. Dr. Vicente T. San Martin reported receiving speaker honoraria from Novo Nordisk.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.